A newly published report in the Journal of the American Medical Association (JAMA) finds that psilocybin-assisted therapy in a group of frontline clinicians during the COVID-19 pandemic “resulted in a significant, sustained reduction of symptoms of depression.” “In this randomized clinical trial, we aimed to investigate whether psilocybin therapy could improve symptoms of depression, burnout, … Continue reading Psychedelic Therapy Reduces Depression Symptoms In Frontline Healthcare Workers, American Medical Association-Published Study Shows